نتائج البحث

Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

• Authors : West China Hospital

• Source: Single-center, Randomized, Double-blind, Placebo-controlled Phase I/II Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine (

تفاصيل العنوان

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

• Authors : West China Hospital

• Source: A Global Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Immunogenicity of Recombinant COVID-19 Vaccine (

تفاصيل العنوان

Evaluation of recombinant baculovirus clearance during rAAV production in Sf9 cells using a newly developed fluorescent-TCID50 assay

• Authors : Ningguang Luo; Xiangqun Chen; Jinzhong Li

Subjects: recombinant adeno-associated virus (rAAV); recombinant baculovirus (rBV); fluorescent-TCID50 (F-TCID50) assay

• Source: Frontiers in Medicine, Vol 11 (2024)

تفاصيل العنوان

Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines

• Authors : Wenxin Luo; Jiadi Gan; Zhu Luo

Subjects: Medicine; Biology (General); QH301-705.5

• Source: Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-9 (2024)

تفاصيل العنوان

Development of an animal-derived component-free medium for Spodoptera frugiperda (Sf9) cells using response surface methodology.

• Authors : Saisud S; Division of Biology, Faculty of Science and Technology, Rajamangala University of Technology, Thanyaburi, Thailand.; Posung M

Subjects: Insecta*; Animals ; Sf9 Cells

• Source: Biotechnology letters [Biotechnol Lett] 2023 Jul; Vol. 45 (7), pp. 761-777. Date of Electronic Publication: 2023 May 15.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8008051 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)

• Authors : West China Hospital

• Source: A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱ Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in

تفاصيل العنوان

Sf9 Cells Metabolism and Viability When Coinfected with Two Monocistronic Baculoviruses to Produce Rabies Virus-like Particles.

• Authors : Leme J; Laboratório de Biotecnologia Viral, Instituto Butantan, Av. Vital Brasil 1500, São Paulo, SP, CEP 05503-900, Brazil.; Guardalini LGO

Subjects: Rabies virus*/Rabies virus*/Rabies virus*/genetics ; Rabies* ; Rabies Vaccines*

• Source: Molecular biotechnology [Mol Biotechnol] 2023 Jun; Vol. 65 (6), pp. 970-982. Date of Electronic Publication: 2022 Nov 18.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Autophagy induced by Vip3Aa has a pro-survival role in Spodoptera frugiperda Sf9 cells

• Authors : Xiaoyue Hou; Lu Han; Baoju An

Subjects: vip3aa; autophagy; autophagosome

• Source: Virulence, Vol 12, Iss 1, Pp 509-519 (2021)

تفاصيل العنوان

Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

• Authors : West China Hospital

• Source: A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱb Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in

تفاصيل العنوان

PHB2 affects the virulence of Vip3Aa to Sf9 cells through internalization and mitochondrial stability

• Authors : Baoju An; Yizhuo Zhang; Xuelian Li

Subjects: Vip3Aa; PHB2; internalization

• Source: Virulence, Vol 13, Iss 1, Pp 684-697 (2022)

تفاصيل العنوان